-
Loading metrics
Development of emodepside as a possible adulticidal treatment for human onchocerciasis—The fruit of a successful industrial–academic collaboration
-
Jürgen Krücken,
Affiliation Institute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin, Berlin, Germany
⨯ -
Lindy Holden-Dye,
Affiliation School of Biological Sciences, Institute for Life Sciences, University of Southampton, Southampton, United Kingdom
⨯ - Jennifer Keiser,
- Roger K. Prichard,
-
Simon Townson,
Affiliation The Griffin Institute, Northwick Park and St. Mark’s Hospital, Harrow, United Kingdom
⨯ -
Benjamin L. Makepeace,
Affiliation Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, United Kingdom
⨯ -
Marc P. Hübner,
Affiliations Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany, German Center for Infection Research (DZIF), partner site Bonn-Cologne, Bonn, Germany
⨯ -
Steffen R. Hahnel,
Affiliation Elanco Animal Health, Research & Exploratory Development, Monheim, Germany
⨯ -
Ivan Scandale,
Affiliation Drugs for Neglected Disease initiative, Geneva, Switzerland
⨯ - Achim Harder,
-
Daniel Kulke
* E-mail: dkulke@iastate.edu
Affiliation Department of Biomedical Sciences, Iowa State University, Ames, Iowa, United States of America
⨯
https://orcid.org/0000-0002-2842-8100
Development of emodepside as a possible adulticidal treatment for human onchocerciasis—The fruit of a successful industrial–academic collaboration
- Jürgen Krücken,
- Lindy Holden-Dye,
- Jennifer Keiser,
- Roger K. Prichard,
- Simon Townson,
- Benjamin L. Makepeace,
- Marc P. Hübner,
- Steffen R. Hahnel,
- Ivan Scandale,
- Achim Harder
- Published: July 22, 2021
- https://doi.org/10.1371/journal.ppat.1009682